Bio-Techne Corp. | Mutual Funds
Mutual Funds that own Bio-Techne Corp.
Eaton Vance SMID Cap Portfolio
1,301,680
3.45%
0
1.93%
04/30/2018
Neuberger Berman Genesis Fund
1,138,147
3.02%
-33,050
1.88%
06/30/2018
Brown Capital Management - Small Company Fund
1,056,807
2.8%
0
3.73%
03/31/2018
iShares Core S&P Mid Cap ETF
1,026,698
2.72%
828
0.39%
09/06/2018
Vanguard Small Cap Index Fund
945,105
2.5%
12,335
0.19%
07/31/2018
Vanguard Total Stock Market Index Fund
943,439
2.5%
5,236
0.02%
07/31/2018
Baron Growth Fund
850,000
2.25%
-3,681
2.27%
06/30/2018
Mairs & Power Growth Fund
795,000
2.11%
-55,000
3.26%
06/29/2018
Janus Triton Fund
680,554
1.8%
0
1.12%
06/30/2018
Vanguard Small Cap Growth Index Fund
539,334
1.43%
7,770
0.4%
07/31/2018
| Address |
614 McKinley Place NE
Minneapolis Minnesota 55413
United States
|
|
Employees
|
- |
| Website |
http://www.bio-techne.com |
| Updated |
07/08/2019 |
| Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It operates through the following segments: Biotechnology, Protein Platforms, Diagnostics, and Corporate. The Biotechnology segment supplies specialized proteins, such as cytokines and growth factors, immunoassays, antibodies and related reagents, as well as in situ hybridization, media and other cell culture products and reagents to the biotechnology research community. |
